Man Group plc - CELLULAR BIOMEDICINE GROUP I ownership

Quarter-by-quarter ownership
Man Group plc ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$3,900,000
-14.2%
212,209
-14.4%
0.02%
-5.6%
Q3 2020$4,545,000
+181.9%
247,838
+130.2%
0.02%
+125.0%
Q2 2020$1,612,000
-27.3%
107,680
-23.2%
0.01%
-42.9%
Q1 2020$2,218,000140,1800.01%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q1 2021
NameSharesValueWeighting ↓
PLATINUM INVESTMENT MANAGEMENT LTD 672,885$11,123,0000.26%
AWM Investment Company, Inc. 80,165$1,325,0000.25%
Nikko Asset Management Americas, Inc. 532,318$8,799,0000.17%
ARK Investment Management 314,378$5,197,0000.13%
Sumitomo Mitsui Trust Holdings, Inc. 528,418$8,735,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,100$531,0000.01%
Mizuho Securities Co. Ltd. 300$5,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 148,815$2,459,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,629$308,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 16,100$237,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders